Humanigen

Humanigen Revenue per Employee

Delisted

The Revenue per Employee of Humanigen (HGENQ) as of Nov 20, 2026 is 251,000.00 USD. In the previous year, Revenue per Employee was 360,000.00 USD — a change of -30.28% (lower).

Revenue per Employee

251,000.00USD

YoY

-30.28%

Last updated:

Revenue per Employee of Humanigen is 2022 251,000.00 USD. Revenue per Employee of Humanigen was 2021 360,000.00 USD. It decreases by -30.28% lower compared to the previous year.

The Humanigen Revenue per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Employee
Date
Revenue per Employee
Jan 1, 2020
31,000.00 USD
Jan 1, 2021
360,000.00 USD
Jan 1, 2022
251,000.00 USD
The Humanigen Revenue per Employee history
YEARRevenue per EmployeeYoY
251,000.00USD-30.28%
360,000.00USD+1,061.29%
31,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Humanigen Stock analysis

What does Humanigen do? Humanigen Inc is a pharmaceutical company specializing in the discovery, development, and marketing of drugs, therapies, and solutions in the field of medical research. The company was originally founded in 2000 and is headquartered in Burlingame, California. One major focus of Humanigen Inc is the treatment of severe and life-threatening diseases such as cancer or HIV/AIDS that have not been sufficiently addressed by other medications. The company has developed a range of special technologies that enable it to develop innovative and effective therapies and drugs. An important aspect of Humanigen Inc's business model is collaboration with other companies, institutions, and research facilities worldwide. Through partnerships and cooperation, the company is able to cover the entire spectrum of research and development, allowing it to develop treatment options even faster and more effectively. Humanigen Inc has several different divisions and products designed for various applications. An important subsidiary of the company is the Humanigen Center for HIV Cure Research, which specifically focuses on combating HIV. There, the company works closely with scientists, researchers, and partners to develop new and innovative treatment options. Another important product of Humanigen Inc is the drug Lenzilumab. Lenzilumab is an antibody used to treat severe and life-threatening diseases such as cancer and COVID-19. Lenzilumab has shown great promise in clinical trials and could be the key to developing new and effective treatment options. In addition, Humanigen Inc has filed a variety of patents that enable it to develop new and innovative technologies in medical research. Many of these technologies are also licensed by other companies and research institutions, promoting the growth and expansion of Humanigen Inc. In recent years, the company has also placed a major focus on the field of digital technology. By utilizing big data, artificial intelligence, and other digital technologies, Humanigen Inc is able to develop new therapy options even faster and more effectively, catering specifically to the needs of patients and doctors. Overall, Humanigen Inc is an innovative and rapidly growing company focused on the development of new and effective treatment options for serious diseases. Through collaboration with other companies and institutions, the development of new technologies, and a targeted focus on the needs of patients and doctors, the company is able to respond even faster and more effectively to challenges in the field of medical research. Humanigen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanigen stock

Revenue per Employee of Humanigen is 251,000.00 USD in 2022.

Revenue per Employee of Humanigen changed from 360,000.00 USD to 251,000.00 USD, representing a -30.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Employee Humanigen since 2006 – with annual values, charts, and detailed analysis.

Revenue per employee measures workforce productivity by dividing total revenue by the number of employees. Higher values indicate more efficient operations.

Revenue per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Revenue per Employee's Humanigen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Humanigen

All Key Metrics — Humanigen